In a recent study, the researchers Saint Louis University found that the loss of at least 9 percent helped patients reverse a type of liver disease known as nonalcoholic steatohepatitis (NASH), a finding that will allow doctors to give patients specific weight-loss goals that are likely to improve their livers.

Study looked at patients with NASH, which is a type of liver disease characterized by excessive fat, causing inflammation and damage to the liver. Researchers set out to see if orlistat, which limits fat absorption, along with calorie restriction lead to weight loss and improve liver disease in overweight patients with NASH, which is determined by a liver biopsy. The Gabriel Method Review

Fifty patients participated in the study, all instructed to consume a 1400 calorie diet and vitamin E, and half also receiving orlistat for 36 weeks, by which time liver biopsies were repeated.

While orlistat itself is not directly linked to improved liver health, weight loss, and, further, the researchers were able to pin-point the percentage of weight loss needed to improve liver damage.Patients who lost 5 percent or more of body weight over nine months showed improvement in insulin resistance and steatosis (fat accumulation in the liver), and those who lost at least 9 percent showed reversal of Their liver damage. For more details

Posted by: kelseydavid124 at 12:23 PM | No Comments | Add Comment
Post contains 221 words, total size 2 kb.